GOSSAMER BIO, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
GOSSAMER BIO, INC. (GOSS) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $290.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-13
- GOSSAMER BIO, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was $290.00K.
- GOSSAMER BIO, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was $1.13M.
- GOSSAMER BIO, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was -$42.00K, a 101.23% decline year-over-year.
- GOSSAMER BIO, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was -$19.00K.
- GOSSAMER BIO, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was -$6.34M, a 511.83% decline from fiscal 2024.
- GOSSAMER BIO, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $1.54M, a 587.05% increase from fiscal 2023.
- GOSSAMER BIO, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $224.00K.
- GOSSAMER BIO, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$619.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $290.00K 10-Q · filed 2026-08-13 | $1.42M 10-Q · filed 2026-08-13 | $1.37M derived: sum of 3 quarters · filed 2026-08-13 | $1.35M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.13M 10-Q · filed 2026-08-13 | $1.08M derived: sum of 2 quarters · filed 2026-08-13 | $1.06M derived: sum of 3 quarters · filed 2026-08-13 | -$3.20M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$61.00K derived: sum of 2 quarters · filed 2026-03-17 | -$4.33M derived: sum of 3 quarters · filed 2026-08-13 | -$6.34M 10-K · filed 2026-03-17 |
| 2025-09-30 | -$19.00K 10-Q · filed 2025-11-05 | -$4.28M derived: sum of 2 quarters · filed 2026-08-13 | -$6.30M 10-Q · filed 2025-11-05 | -$2.88M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$4.26M 10-Q · filed 2026-08-13 | -$6.28M 10-Q · filed 2026-08-13 | -$2.86M derived: sum of 3 quarters · filed 2026-08-13 | -$4.57M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$2.01M 10-Q · filed 2026-08-13 | $1.41M derived: sum of 2 quarters · filed 2026-08-13 | -$306.00K derived: sum of 3 quarters · filed 2026-08-13 | -$196.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2024-12-31 | $3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $1.71M derived: sum of 2 quarters · filed 2026-03-17 | $1.82M derived: sum of 3 quarters · filed 2026-03-17 | $1.54M 10-K · filed 2026-03-17 |
| 2024-09-30 | -$1.71M 10-Q · filed 2025-11-05 | -$1.60M derived: sum of 2 quarters · filed 2025-11-05 | -$1.88M 10-Q · filed 2025-11-05 | -$1.61M derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-06-30 | $110.00K 10-Q · filed 2025-11-05 | -$168.00K 10-Q · filed 2025-08-05 | $100.00K derived: sum of 3 quarters · filed 2026-03-17 | -$37.00K derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-03-31 | -$278.00K 10-Q · filed 2025-11-05 | -$10.00K derived: sum of 2 quarters · filed 2026-03-17 | -$147.00K derived: sum of 3 quarters · filed 2026-03-17 | -$192.00K derived: sum of 4 quarters · filed 2026-03-17 |
| 2023-12-31 | $268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $131.00K derived: sum of 2 quarters · filed 2026-03-17 | $86.00K derived: sum of 3 quarters · filed 2026-03-17 | $224.00K 10-K · filed 2026-03-17 |
| 2023-09-30 | -$137.00K 10-Q · filed 2024-11-07 | -$182.00K derived: sum of 2 quarters · filed 2024-11-07 | -$44.00K 10-Q · filed 2024-11-07 | -$33.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | -$45.00K 10-Q · filed 2024-11-07 | $93.00K 10-Q · filed 2024-08-12 | $104.00K derived: sum of 3 quarters · filed 2025-03-13 | $33.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | $138.00K 10-Q · filed 2024-11-07 | $149.00K derived: sum of 2 quarters · filed 2025-03-13 | $78.00K derived: sum of 3 quarters · filed 2025-03-13 | -$96.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$60.00K derived: sum of 2 quarters · filed 2025-03-13 | -$234.00K derived: sum of 3 quarters · filed 2025-03-13 | -$619.00K 10-K · filed 2025-03-13 |
| 2022-09-30 | -$71.00K 10-Q · filed 2023-11-09 | -$245.00K derived: sum of 2 quarters · filed 2023-11-09 | -$630.00K 10-Q · filed 2023-11-09 | -$722.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | -$174.00K 10-Q · filed 2023-11-09 | -$559.00K 10-Q · filed 2023-08-08 | -$651.00K derived: sum of 3 quarters · filed 2024-03-05 | -$788.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | -$385.00K 10-Q · filed 2023-11-09 | -$477.00K derived: sum of 2 quarters · filed 2024-03-05 | -$614.00K derived: sum of 3 quarters · filed 2024-03-05 | -$498.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | -$92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$229.00K derived: sum of 2 quarters · filed 2024-03-05 | -$113.00K derived: sum of 3 quarters · filed 2024-03-05 | -$554.00K 10-K · filed 2024-03-05 |
| 2021-09-30 | -$137.00K 10-Q · filed 2022-11-03 | -$21.00K derived: sum of 2 quarters · filed 2022-11-03 | -$462.00K 10-Q · filed 2022-11-03 | -$205.00K derived: sum of 4 quarters · filed 2023-03-17 |
| 2021-06-30 | $116.00K 10-Q · filed 2022-11-03 | -$325.00K 10-Q · filed 2022-08-09 | -$68.00K derived: sum of 3 quarters · filed 2023-03-17 | -$293.00K derived: sum of 4 quarters · filed 2023-03-17 |
| 2021-03-31 | -$441.00K 10-Q · filed 2022-11-03 | -$184.00K derived: sum of 2 quarters · filed 2023-03-17 | -$409.00K derived: sum of 3 quarters · filed 2023-03-17 | $663.00K derived: sum of 4 quarters · filed 2023-03-17 |
| 2020-12-31 | $257.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $32.00K derived: sum of 2 quarters · filed 2023-03-17 | $1.10M derived: sum of 3 quarters · filed 2023-03-17 | $341.00K 10-K · filed 2023-03-17 |
| 2020-09-30 | -$225.00K 10-Q · filed 2021-11-08 | $847.00K derived: sum of 2 quarters · filed 2021-11-08 | $84.00K 10-Q · filed 2021-11-08 | $14.00K derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-06-30 | $1.07M 10-Q · filed 2021-11-08 | $309.00K 10-Q · filed 2021-08-09 | $239.00K derived: sum of 3 quarters · filed 2022-03-03 | $71.00K derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-03-31 | -$763.00K 10-Q · filed 2021-11-08 | -$833.00K derived: sum of 2 quarters · filed 2022-03-03 | -$1.00M derived: sum of 3 quarters · filed 2022-03-03 | -$584.00K derived: sum of 4 quarters · filed 2022-03-03 |
| 2019-12-31 | -$70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$238.00K derived: sum of 2 quarters · filed 2022-03-03 | $179.00K derived: sum of 3 quarters · filed 2022-03-03 | $319.00K 10-K · filed 2022-03-03 |
| 2019-09-30 | -$168.00K 10-Q · filed 2020-11-10 | $249.00K derived: sum of 2 quarters · filed 2020-11-10 | $389.00K 10-Q · filed 2020-11-10 | $93.00K derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $417.00K 10-Q · filed 2020-11-10 | $557.00K 10-Q · filed 2020-08-11 | $261.00K derived: sum of 3 quarters · filed 2021-02-26 | $493.00K derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $140.00K 10-Q · filed 2020-11-10 | -$156.00K derived: sum of 2 quarters · filed 2021-02-26 | $76.00K derived: sum of 3 quarters · filed 2021-02-26 | $79.00K derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$296.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$64.00K derived: sum of 2 quarters · filed 2021-02-26 | -$61.00K derived: sum of 3 quarters · filed 2021-02-26 | -$61.00K 10-K · filed 2021-02-26 |
| 2018-09-30 | $232.00K 10-Q · filed 2019-11-12 | $235.00K derived: sum of 2 quarters · filed 2019-11-12 | $235.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $3.00K 10-Q · filed 2019-11-12 | $3.00K 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 |